NCT01374360View on ClinicalTrials.gov

Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry

CompletedOBSERVATIONAL
Enrollment

6,061

Participants

Timeline

Start Date

October 29, 2004

Primary Completion Date

August 6, 2024

Study Completion Date

August 6, 2024

Conditions
Paroxysmal Nocturnal Hemoglobinuria
Trial Locations (1)

02210

Contact the PNH Registry at Alexion Pharmaceuticals, Inc. for worldwide locations., Boston

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY